Market Size of Global Sacral Nerve Stimulation Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 5.50 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Sacral Nerve Stimulation Market Analysis
The Sacral Nerve Stimulation Market is expected to register a CAGR of 5.5% over the forecast period (2022-2027).
The impact of the COVID-19 outbreak on the sacral nerve stimulation market is expected to be significant, as most non-COVID treatment services were disrupted to reserve the healthcare infrastructure for COVID-19-infected patients and minimize the risk of transmission of the SARS-CoV-2 virus. According to a study published in the British Journal of Surgery in May 2020, due to 12 weeks of peak disruption in hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed and reviews suggest that between 16% to 20% of these surgical procedures constitute of sacral nerve surgical procedures, impacting the sacral nerve stimulation market. Additionally, according to a research study by Jeremy Yuen-Chun Teoh et al., titled " A Global Survey on the Impact of COVID-19 on Urological Services" (2020), globally, the outpatient clinics for female urinary incontinence, benign prostatic hyperplasia, infertility, and sexual medicine, benign scrotal conditions, renal stone, and bladder stone were the most affected by the pandemic. Also, a delay of more than eight weeks for urological services was reported for 28% of all outpatient clinics, 30% of all outpatient investigations and procedures, and 31% of all urological surgeries during the COVID-19 pandemic. Hence, given the facts, the studied market is predicted to be negatively impacted due to the COVID-19 pandemic.
The rising prevalence of overactive bladder conditions and the increasing incidence of urge incontinence, such as urinary tract infection (UTI), are the major drivers for the growth of the market studied. Also, the growing incidence of fecal incontinence and the availability of medical reimbursements are some other factors fueling the market growth. For instance, in 2021, an article titled, 'Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories' reported that globally, urinary tract infection (UTI) was attributed to the most disability-adjusted life-years (DALYs) among the three diseases reported in the article and about 68.89% of individuals were infected with urinary tract infections (UTI) globally during the study period.
Furthermore, the prevalence of urinary incontinence is more in women than in men. For instance, according to a research study by Sedighe Batman et al., published in the BMC Geriatrics Journal in March 2021, the highest prevalence of urinary incontinence was reported to be in older adult women in Asia (45.1%). Some factors influencing the incidence of urinary incontinence in older women are age, obesity, diabetes, hypertension, and smoking. Thus, the growing target patient pool may drive the demand for treatment and promote the sacral nerve stimulation market in the coming years. Furthermore, the rising geriatric population globally is driving the market.
Thus, increasing aging along with growing research investments, and technological advancements associated with the development of novel medical devices are expected to drive the market. However, health risks associated with the devices are expected to slow down the market over the forecast period.
Sacral Nerve Stimulation Industry Segmentation
As per the scope of the report, sacral nerve stimulation also referred to as sacral neuromodulation therapy, is a reversible treatment that uses a device to send electrical impulses to sacral nerves that control bladder functions. This treatment is adopted by patients who have fecal and urinary dysfunction. The sacral nerve stimulation market is segmented by Product Type (External Sacral Nerve Stimulation, Implantable Sacral Nerve Stimulation), Application (Urge Incontinence, Urinary, and Fecal Incontinence, Chronic Anal Fissure, and Other Applications), End-Users (Hospitals, Ambulatory Surgical Centers, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product | |
External Sacral Nerve Stimulation | |
Implantable Sacral Nerve Stimulation |
By Applications | |
Urge Incontinence | |
Urinary and Fecal Incontinence | |
Chronic Anal Fissure | |
Other Applications |
By End-Users | |
Hospitals | |
Ambulatory Surgical Centers | |
Other End-Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Sacral Nerve Stimulation Market Size Summary
The sacral nerve stimulation market is poised for growth, driven by the increasing prevalence of overactive bladder conditions and urge incontinence, alongside the rising incidence of fecal incontinence. The market's expansion is further supported by the availability of medical reimbursements and advancements in medical technology. The growing geriatric population, particularly among women, is a significant factor contributing to the demand for sacral nerve stimulation treatments. Despite the challenges posed by the COVID-19 pandemic, which disrupted elective surgeries and outpatient services, the market is expected to recover and continue its upward trajectory. The development of novel medical devices and the increasing focus on research and development by key players are anticipated to bolster market growth over the forecast period.
North America is expected to maintain a significant share of the sacral nerve stimulation market, driven by the high prevalence of overactive bladder conditions and the adoption of advanced medical devices. The region benefits from a well-established healthcare infrastructure, favorable reimbursement policies, and the presence of major market players. The increasing demand for minimally invasive surgeries and the high incidence of diabetes, which contributes to urinary tract infections, further support market growth in North America. The competitive landscape is characterized by a fragmented market with several international and regional companies, including Medtronic, Axonics Modulation Technologies, and Nuvectra Corporation, among others. These companies are actively involved in strategic alliances and product innovations to enhance their market presence and cater to the growing demand for sacral nerve stimulation therapies.
Global Sacral Nerve Stimulation Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Overactive Bladder Conditions
-
1.2.2 Increasing Incidence of Urge Incontinence
-
-
1.3 Market Restraints
-
1.3.1 Health Risks Associated with the Devices
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 External Sacral Nerve Stimulation
-
2.1.2 Implantable Sacral Nerve Stimulation
-
-
2.2 By Applications
-
2.2.1 Urge Incontinence
-
2.2.2 Urinary and Fecal Incontinence
-
2.2.3 Chronic Anal Fissure
-
2.2.4 Other Applications
-
-
2.3 By End-Users
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Other End-Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Sacral Nerve Stimulation Market Size FAQs
What is the current Global Sacral Nerve Stimulation Market size?
The Global Sacral Nerve Stimulation Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)
Who are the key players in Global Sacral Nerve Stimulation Market?
Nuvectra, Medtronic, NeuroPace, Inc., Laborie, Inc and Axonics Modulation Technologies, Inc. are the major companies operating in the Global Sacral Nerve Stimulation Market.